 | • レポートコード：MRC2102QY0130 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の医薬品有効成分（API）市場について種類別（合成API、バイオテクノロジーAPI）、用途別（中枢神経系、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・医薬品有効成分（API）市場の概要 ・世界の主要地域別医薬品有効成分（API）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の医薬品有効成分（API）市場規模2015-2026：種類別（合成API、バイオテクノロジーAPI） ・世界の医薬品有効成分（API）市場規模2015-2026：用途別（中枢神経系、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他） ・医薬品有効成分（API）の米国市場規模2015-2020 ・医薬品有効成分（API）のヨーロッパ市場規模2015-2020 ・医薬品有効成分（API）の中国市場規模2015-2020 ・医薬品有効成分（API）の日本市場規模2015-2020 ・医薬品有効成分（API）の東南アジア市場規模2015-2020 ・医薬品有効成分（API）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・医薬品有効成分（API）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・医薬品有効成分（API）の市場動向・機会・課題 ・調査の結論 |
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Active Pharmaceutical Ingredients (API) Market
The global Active Pharmaceutical Ingredients (API) market size is projected to reach US$ 99230 million by 2026, from US$ 67700 million in 2020, at a CAGR of 6.6% during 2021-2026.
Global Active Pharmaceutical Ingredients (API) Scope and Market Size
The global Active Pharmaceutical Ingredients (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredients (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Active Pharmaceutical Ingredients (API) market is segmented into
Synthetic APIs
Biotech APIs
Segment by Application, the Active Pharmaceutical Ingredients (API) market is segmented into
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
The Active Pharmaceutical Ingredients (API) market is analysed and market size information is provided by regions (countries). Segment by Application, the Active Pharmaceutical Ingredients (API) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Active Pharmaceutical Ingredients (API) Market Share Analysis
Active Pharmaceutical Ingredients (API) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Active Pharmaceutical Ingredients (API) business, the date to enter into the Active Pharmaceutical Ingredients (API) market, Active Pharmaceutical Ingredients (API) product introduction, recent developments, etc.
The major vendors covered:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Active Pharmaceutical Ingredients (API) Product Scope
1.2 Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Sales by Type (2020-2026)
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Global Active Pharmaceutical Ingredients (API) Sales Comparison by Application (2020-2026)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2026)
1.4.2 Global Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2015-2026)
1.4.3 Global Active Pharmaceutical Ingredients (API) Price Trends (2015-2026)
2 Active Pharmaceutical Ingredients (API) Estimate and Forecast by Region
2.1 Global Active Pharmaceutical Ingredients (API) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2015-2020)
2.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)
2.3 Global Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Active Pharmaceutical Ingredients (API) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Active Pharmaceutical Ingredients (API) Estimates and Projections (2015-2026)
2.4.2 Europe Active Pharmaceutical Ingredients (API) Estimates and Projections (2015-2026)
2.4.3 China Active Pharmaceutical Ingredients (API) Estimates and Projections (2015-2026)
2.4.4 Japan Active Pharmaceutical Ingredients (API) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Active Pharmaceutical Ingredients (API) Estimates and Projections (2015-2026)
2.4.6 India Active Pharmaceutical Ingredients (API) Estimates and Projections (2015-2026)
3 Global Active Pharmaceutical Ingredients (API) Competition Landscape by Players
3.1 Global Top Active Pharmaceutical Ingredients (API) Players by Sales (2015-2020)
3.2 Global Top Active Pharmaceutical Ingredients (API) Players by Revenue (2015-2020)
3.3 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2019)
3.4 Global Active Pharmaceutical Ingredients (API) Average Price by Company (2015-2020)
3.5 Manufacturers Active Pharmaceutical Ingredients (API) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Active Pharmaceutical Ingredients (API) Players (Opinion Leaders)
4 Global Active Pharmaceutical Ingredients (API) Market Size by Type
4.1 Global Active Pharmaceutical Ingredients (API) Historic Market Review by Type (2015-2020)
4.1.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2015-2020)
4.1.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2015-2020)
4.2 Global Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2021-2026)
4.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2021-2026)
4.2.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2021-2026)
5 Global Active Pharmaceutical Ingredients (API) Market Size by Application
5.1 Global Active Pharmaceutical Ingredients (API) Historic Market Review by Application (2015-2020)
5.1.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
5.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2015-2020)
5.1.3 Global Active Pharmaceutical Ingredients (API) Price by Application (2015-2020)
5.2 Global Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2021-2026)
5.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2021-2026)
5.2.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2021-2026)
6 United States Active Pharmaceutical Ingredients (API) Market Facts & Figures
6.1 United States Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
6.2 United States Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
6.3 United States Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
7 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures
7.1 Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
7.2 Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
7.3 Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
8 China Active Pharmaceutical Ingredients (API) Market Facts & Figures
8.1 China Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
8.2 China Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
8.3 China Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
9 Japan Active Pharmaceutical Ingredients (API) Market Facts & Figures
9.1 Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Company (3015-3030)
9.2 Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
9.3 Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
10 Southeast Asia Active Pharmaceutical Ingredients (API) Market Facts & Figures
10.1 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
11 India Active Pharmaceutical Ingredients (API) Market Facts & Figures
11.1 India Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
11.2 India Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
11.3 India Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Active Pharmaceutical Ingredients (API) Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
12.1.5 Teva Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mylan Active Pharmaceutical Ingredients (API) Products Offered
12.2.5 Mylan Recent Development
12.3 DSM
12.3.1 DSM Corporation Information
12.3.2 DSM Business Overview
12.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 DSM Active Pharmaceutical Ingredients (API) Products Offered
12.3.5 DSM Recent Development
12.4 Aurobindo Pharma
12.4.1 Aurobindo Pharma Corporation Information
12.4.2 Aurobindo Pharma Business Overview
12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Products Offered
12.4.5 Aurobindo Pharma Recent Development
12.5 Aspen
12.5.1 Aspen Corporation Information
12.5.2 Aspen Business Overview
12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Aspen Active Pharmaceutical Ingredients (API) Products Offered
12.5.5 Aspen Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Active Pharmaceutical Ingredients (API) Products Offered
12.6.5 Novartis Recent Development
12.7 BASF
12.7.1 BASF Corporation Information
12.7.2 BASF Business Overview
12.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 BASF Active Pharmaceutical Ingredients (API) Products Offered
12.7.5 BASF Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Business Overview
12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Active Pharmaceutical Ingredients (API) Products Offered
12.8.5 Pfizer Recent Development
12.9 Huahai Pharmaceutical
12.9.1 Huahai Pharmaceutical Corporation Information
12.9.2 Huahai Pharmaceutical Business Overview
12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.9.5 Huahai Pharmaceutical Recent Development
12.10 Hisun Pharmaceutical
12.10.1 Hisun Pharmaceutical Corporation Information
12.10.2 Hisun Pharmaceutical Business Overview
12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.10.5 Hisun Pharmaceutical Recent Development
12.11 Sun Pharmaceutical Industries
12.11.1 Sun Pharmaceutical Industries Corporation Information
12.11.2 Sun Pharmaceutical Industries Business Overview
12.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Products Offered
12.11.5 Sun Pharmaceutical Industries Recent Development
12.12 Zhejiang Medicine
12.12.1 Zhejiang Medicine Corporation Information
12.12.2 Zhejiang Medicine Business Overview
12.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Products Offered
12.12.5 Zhejiang Medicine Recent Development
12.13 Dr. Reddy’s Laboratories
12.13.1 Dr. Reddy’s Laboratories Corporation Information
12.13.2 Dr. Reddy’s Laboratories Business Overview
12.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Products Offered
12.13.5 Dr. Reddy’s Laboratories Recent Development
12.14 Zhejiang NHU
12.14.1 Zhejiang NHU Corporation Information
12.14.2 Zhejiang NHU Business Overview
12.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Products Offered
12.14.5 Zhejiang NHU Recent Development
12.15 Bayer
12.15.1 Bayer Corporation Information
12.15.2 Bayer Business Overview
12.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Bayer Active Pharmaceutical Ingredients (API) Products Offered
12.15.5 Bayer Recent Development
12.16 NCPC
12.16.1 NCPC Corporation Information
12.16.2 NCPC Business Overview
12.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 NCPC Active Pharmaceutical Ingredients (API) Products Offered
12.16.5 NCPC Recent Development
12.17 AbbVie
12.17.1 AbbVie Corporation Information
12.17.2 AbbVie Business Overview
12.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.17.4 AbbVie Active Pharmaceutical Ingredients (API) Products Offered
12.17.5 AbbVie Recent Development
12.18 Shandong Xinhua Pharmaceutical
12.18.1 Shandong Xinhua Pharmaceutical Corporation Information
12.18.2 Shandong Xinhua Pharmaceutical Business Overview
12.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.18.5 Shandong Xinhua Pharmaceutical Recent Development
12.19 Northeast Pharm
12.19.1 Northeast Pharm Corporation Information
12.19.2 Northeast Pharm Business Overview
12.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Products Offered
12.19.5 Northeast Pharm Recent Development
12.20 Harbin Pharmaceutical
12.20.1 Harbin Pharmaceutical Corporation Information
12.20.2 Harbin Pharmaceutical Business Overview
12.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.20.5 Harbin Pharmaceutical Recent Development
12.21 LKPC
12.21.1 LKPC Corporation Information
12.21.2 LKPC Business Overview
12.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2015-2020)
12.21.4 LKPC Active Pharmaceutical Ingredients (API) Products Offered
12.21.5 LKPC Recent Development
13 Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis
13.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
13.4 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Active Pharmaceutical Ingredients (API) Distributors List
14.3 Active Pharmaceutical Ingredients (API) Customers
15 Market Dynamics
15.1 Active Pharmaceutical Ingredients (API) Market Trends
15.2 Active Pharmaceutical Ingredients (API) Opportunities and Drivers
15.3 Active Pharmaceutical Ingredients (API) Market Challenges
15.4 Active Pharmaceutical Ingredients (API) Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Active Pharmaceutical Ingredients (API) Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Active Pharmaceutical Ingredients (API) Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Active Pharmaceutical Ingredients (API) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Active Pharmaceutical Ingredients (API) Sales (K MT) by Region (2015-2020)
Table 5. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2015-2020)
Table 6. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Active Pharmaceutical Ingredients (API) Revenue Share by Region (2015-2020)
Table 8. Global Active Pharmaceutical Ingredients (API) Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Active Pharmaceutical Ingredients (API) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Active Pharmaceutical Ingredients (API) (K MT) of Key Companies (2015-2020)
Table 13. Global Active Pharmaceutical Ingredients (API) Sales Share by Company (2015-2020)
Table 14. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Active Pharmaceutical Ingredients (API) Revenue Share by Company (2015-2020)
Table 16. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2019)
Table 17. Global Active Pharmaceutical Ingredients (API) Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Active Pharmaceutical Ingredients (API) Manufacturing Sites and Area Served
Table 19. Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Active Pharmaceutical Ingredients (API) Players
Table 22. Global Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2015-2020)
Table 23. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2015-2020)
Table 24. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Active Pharmaceutical Ingredients (API) Price (K MT) by Type (2015-2020)
Table 26. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2021-2026)
Table 27. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2021-2026)
Table 29. Global Active Pharmaceutical Ingredients (API) Price (K MT) by Type (2021-2026)
Table 30. Global Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2015-2020)
Table 31. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2015-2020)
Table 32. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Active Pharmaceutical Ingredients (API) Price (K MT) by Application (2015-2020)
Table 34. Global Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2021-2026)
Table 35. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2021-2026)
Table 36. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2021-2026)
Table 38. Global Active Pharmaceutical Ingredients (API) Price (K MT) by Application (2021-2026)
Table 39. United States Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2015-2020)
Table 40. United States Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
Table 41. United States Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2015-2020)
Table 42. United States Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 43. United States Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2015-2020)
Table 44. United States Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 45. Europe Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2015-2020)
Table 46. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
Table 47. Europe Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2015-2020)
Table 48. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 49. Europe Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2015-2020)
Table 50. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 51. China Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2015-2020)
Table 52. China Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
Table 53. China Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2015-2020)
Table 54. China Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 55. China Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2015-2020)
Table 56. China Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 57. Japan Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2015-2020)
Table 58. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
Table 59. Japan Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2015-2020)
Table 60. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 61. Japan Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2015-2020)
Table 62. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 69. India Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2015-2020)
Table 70. India Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2015-2020)
Table 71. India Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2015-2020)
Table 72. India Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 73. India Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2015-2020)
Table 74. India Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Teva Active Pharmaceutical Ingredients (API) Product
Table 79. Teva Recent Development
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Mylan Active Pharmaceutical Ingredients (API) Product
Table 84. Mylan Recent Development
Table 85. DSM Corporation Information
Table 86. DSM Description and Business Overview
Table 87. DSM Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. DSM Active Pharmaceutical Ingredients (API) Product
Table 89. DSM Recent Development
Table 90. Aurobindo Pharma Corporation Information
Table 91. Aurobindo Pharma Description and Business Overview
Table 92. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product
Table 94. Aurobindo Pharma Recent Development
Table 95. Aspen Corporation Information
Table 96. Aspen Description and Business Overview
Table 97. Aspen Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Aspen Active Pharmaceutical Ingredients (API) Product
Table 99. Aspen Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Novartis Active Pharmaceutical Ingredients (API) Product
Table 104. Novartis Recent Development
Table 105. BASF Corporation Information
Table 106. BASF Description and Business Overview
Table 107. BASF Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. BASF Active Pharmaceutical Ingredients (API) Product
Table 109. BASF Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Pfizer Description and Business Overview
Table 113. Pfizer Active Pharmaceutical Ingredients (API) Product
Table 114. Pfizer Recent Development
Table 115. Huahai Pharmaceutical Corporation Information
Table 116. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Huahai Pharmaceutical Description and Business Overview
Table 118. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 119. Huahai Pharmaceutical Recent Development
Table 120. Hisun Pharmaceutical Corporation Information
Table 121. Hisun Pharmaceutical Description and Business Overview
Table 122. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 124. Hisun Pharmaceutical Recent Development
Table 125. Sun Pharmaceutical Industries Corporation Information
Table 126. Sun Pharmaceutical Industries Description and Business Overview
Table 127. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product
Table 129. Sun Pharmaceutical Industries Recent Development
Table 130. Zhejiang Medicine Corporation Information
Table 131. Zhejiang Medicine Description and Business Overview
Table 132. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product
Table 134. Zhejiang Medicine Recent Development
Table 135. Dr. Reddy’s Laboratories Corporation Information
Table 136. Dr. Reddy’s Laboratories Description and Business Overview
Table 137. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product
Table 139. Dr. Reddy’s Laboratories Recent Development
Table 140. Zhejiang NHU Corporation Information
Table 141. Zhejiang NHU Description and Business Overview
Table 142. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product
Table 144. Zhejiang NHU Recent Development
Table 145. Bayer Corporation Information
Table 146. Bayer Description and Business Overview
Table 147. Bayer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Bayer Active Pharmaceutical Ingredients (API) Product
Table 149. Bayer Recent Development
Table 150. NCPC Corporation Information
Table 151. NCPC Description and Business Overview
Table 152. NCPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. NCPC Active Pharmaceutical Ingredients (API) Product
Table 154. NCPC Recent Development
Table 155. AbbVie Corporation Information
Table 156. AbbVie Description and Business Overview
Table 157. AbbVie Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. AbbVie Active Pharmaceutical Ingredients (API) Product
Table 159. AbbVie Recent Development
Table 160. Shandong Xinhua Pharmaceutical Corporation Information
Table 161. Shandong Xinhua Pharmaceutical Description and Business Overview
Table 162. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 164. Shandong Xinhua Pharmaceutical Recent Development
Table 165. Northeast Pharm Corporation Information
Table 166. Northeast Pharm Description and Business Overview
Table 167. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Northeast Pharm Active Pharmaceutical Ingredients (API) Product
Table 169. Northeast Pharm Recent Development
Table 170. Harbin Pharmaceutical Corporation Information
Table 171. Harbin Pharmaceutical Description and Business Overview
Table 172. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 174. Harbin Pharmaceutical Recent Development
Table 175. LKPC Corporation Information
Table 176. LKPC Description and Business Overview
Table 177. LKPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. LKPC Active Pharmaceutical Ingredients (API) Product
Table 179. LKPC Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Active Pharmaceutical Ingredients (API) Distributors List
Table 183. Active Pharmaceutical Ingredients (API) Customers List
Table 184. Active Pharmaceutical Ingredients (API) Market Key Trends
Table 185. Active Pharmaceutical Ingredients (API) Key Opportunities and Drivers
Table 186. Active Pharmaceutical Ingredients (API) Market Challenges
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) Product Picture
Figure 2. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Active Pharmaceutical Ingredients (API) Market Share by Application in 2020 & 2026
Figure 6. CNS Examples
Figure 7. Cardiovascular Examples
Figure 8. Genitourinary/Hormonal Drugs Examples
Figure 9. Respiratory Examples
Figure 10. Rheumatology Examples
Figure 11. Diabetes Examples
Figure 12. Oncology Examples
Figure 13. Others Examples
Figure 14. Global Active Pharmaceutical Ingredients (API) Sales (K MT) Growth Rate (2015-2026)
Figure 15. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 16. Global Active Pharmaceutical Ingredients (API) Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 17. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region: 2015 VS 2020
Figure 18. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region: 2021 VS 2026
Figure 19. United States Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. United States Active Pharmaceutical Ingredients (API) Sales (K MT) Growth Rate (2015-2026)
Figure 21. Europe Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Europe Active Pharmaceutical Ingredients (API) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. China Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. China Active Pharmaceutical Ingredients (API) Sales (Million USD) and Growth Rate (2015-2026)
Figure 25. Japan Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Japan Active Pharmaceutical Ingredients (API) Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. Southeast Asia Active Pharmaceutical Ingredients (API) Sales (Million USD) Growth Rate (2015-2026)
Figure 29. India Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 30. India Active Pharmaceutical Ingredients (API) Sales (Million USD) Growth Rate (2015-2026)
Figure 31. Global 5 Largest Active Pharmaceutical Ingredients (API) Players Market Share by Revenue in Active Pharmaceutical Ingredients (API) 2015 & 2019
Figure 32. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 33. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2015-2020)
Figure 34. Global Active Pharmaceutical Ingredients (API) Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2015-2020)
Figure 36. Global Active Pharmaceutical Ingredients (API) Revenue Growth Rate by Application in 2015 & 2019
Figure 37. United States Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2019
Figure 38. United States Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2019
Figure 39. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Company in 2019
Figure 40. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2019
Figure 41. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2019
Figure 42. China Active Pharmaceutical Ingredients (API) Sales Market Share by Company in 2019
Figure 43. China Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2019
Figure 44. China Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2019
Figure 45. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Company in 2019
Figure 46. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2019
Figure 47. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2019
Figure 48. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Company in 2019
Figure 49. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2019
Figure 50. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2019
Figure 51. India Active Pharmaceutical Ingredients (API) Sales Market Share by Company in 2019
Figure 52. India Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2019
Figure 53. India Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2019
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Active Pharmaceutical Ingredients (API)
Figure 56. Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
Figure 57. Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
パーソナルケア有効成分の世界市場レポート2020 Personal care active ingredients are series of raw materials used in personal care products, which include the surfactants conditioning polymer emulsifier and emollients etc. and mainly used in skin care hair care cosmetic and oral care products etc. This report researches and analyzes the surfactan…- API（医薬品有効成分）中間体の世界市場レポート2020 Market Analysis and Insights: Global API(Active Pharmaceutical Ingredient) Intermediate Market The global API(Active Pharmaceutical Ingredient) Intermediate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global API(Active Pha…
- 低分子医薬品有効成分の世界市場レポート2020 Market Analysis and Insights: Global Small Molecule Active Pharmaceutical Ingredient Market The global Small Molecule Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Small Molecule Activ…
- パーソナルケア特殊成分の世界市場レポート2020 Market Analysis and Insights: Global Personal Care Specialty Ingredients Market The global Personal Care Specialty Ingredients market size is projected to reach US$ 15980 million by 2026, from US$ 11630 million in 2020, at a CAGR of 5.4% during 2021-2026. Global Personal Care Specialty Ingredients S…
- アクティブシートベルトの世界市場レポート2020 Active seat belts are similar to traditional seat belts, but with advanced technology that automatically detects threats, such as collisions, and tightens the seat belt to provide better safety precautions. The leading manufactures mainly are Autoliv, ZF, Continental and Joyson. Autoliv is the large…